| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2016: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Outline of Final Research Achievements |
Understanding functional characteristics of T-cell responses associated with effective elimination of pathogenic retroviruses or tumors is crucial for the development of vaccines. In this study, we demonstrated that the use of an appropriate epitope preferentially induces functional T cell responses in the early phase of acute retroviral infection that contribute to the effective antiviral protection, providing a better information for the development of vaccine.
|
